Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EABcr-abl tyrosine kinase inhibitors
- Chemical substanceL01EA03Nilotinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Serbia
ALIMS · 27 registrations
- Nilmat®200mg · kapsula, tvrda · Galenika Ad Beograd · 3 entries
- Nilmat®150mg · kapsula, tvrda · Galenika Ad Beograd
Croatia
HALMED · 22 registrations
At a glance
- ATC code
- L01EA03
- Registers
- 10
- Historical lists
- 2
- Registrations
- 113
- With their own page
- 105
- Companies
- 33
All medicines with Nilotinib
Human medicines from every register that match Nilotinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
113 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Nilotinib Accord | European Union | Authorised | Accord Healthcare S.L.U. | ||
| Nilotinib D-Tartrate | United States | 150MG BASE, 200MG BASE, 50MG BASE | capsule | Marketed | Cipla |
| Nilotinib STADA | Serbia | 200mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 150mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 200mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 150mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 200mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 200mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 50mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 150mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 200mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 50mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 200mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 150mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 150mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 50mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 50mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 50mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 50mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib STADA | Serbia | 150mg | kapsula, tvrda | Authorised | Hemofarm Ad VRŠAc |
| Nilotinib Hydrochloride | United States | 150MG BASE, 200MG BASE, 50MG BASE | capsule | Marketed | Torrent |
| Nilotinib Accord | Croatia | Marketed | |||
| Nilotinib Teva 150 MG Capsulas Duras Efg | Spain | 170,54 mg | cápsula dura | Marketed | Teva Gmbh |
| Nilotinib Teva 200 MG Capsulas Duras Efg | Spain | 227,38 mg | cápsula dura | Marketed | Teva Gmbh |
| Nilotinib CF 150 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Centrafarm B.V. |